Experts Want Labels For Pfizer, Moderna COVID-19 Vaccines Updated To Acknowledge Limitations

The group

A coalition of experts is calling for U.S. officials to update the labels for the Pfizer and Moderna COVID-19 vaccines to acknowledge limitations to clinical trials, including stating clearly that the phase III trials that led to clearance did not provide evidence of efficacy against death.

Continue reading Here